2020
DOI: 10.3949/ccjm.87a.ccc014
|View full text |Cite
|
Sign up to set email alerts
|

Utility of extracorporeal membrane oxygenation in COVID-19

Abstract: The statements and opinions expressed in COVID-19 Curbside Consults are based on experience and the available literature as of the date posted. While we try to regularly update this content, any offered recommendations cannot be substituted for the clinical judgment of clinicians caring for individual patients. ABSTRACT Extracorporeal membrane oxygenation (ECMO) is a means of cardiopulmonary support for refractory respiratory and cardiac failure. ECMO is a resource-intensive therapy that can be considered in h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 11 publications
0
8
0
Order By: Relevance
“…The first is that the laboratory investigations in this tool are in addition to the routine laboratory evaluations such as CBC, ESR, CRP, and blood glucose. Secondly, it should be borne in mind that for consideration of mechanical circulatory support, the conventional indications and contraindications in patients with COVID-19, in addition to the precautions for prevention and treatment of infections, should be strictly followed [109][110][111].…”
Section: Triage Risk Stratification Tool For Patients With Covid-19 Amentioning
confidence: 99%
“…The first is that the laboratory investigations in this tool are in addition to the routine laboratory evaluations such as CBC, ESR, CRP, and blood glucose. Secondly, it should be borne in mind that for consideration of mechanical circulatory support, the conventional indications and contraindications in patients with COVID-19, in addition to the precautions for prevention and treatment of infections, should be strictly followed [109][110][111].…”
Section: Triage Risk Stratification Tool For Patients With Covid-19 Amentioning
confidence: 99%
“…Improvement in mortality with ECMO was reported in the non-randomized studies during the influenza A H1N1 epidemic in 2009 and the Middle East respiratory syndrome coronavirus epidemic in 2014, supporting the use of ECMO for refractory hypoxemia. 11 - 13 …”
Section: Discussionmentioning
confidence: 99%
“…Patients with advanced age, terminal diseases such as advanced malignancy, severe multiorgan failure, severe neurologic damage such as anoxic brain injury, inability to receive blood transfusions, or anticoagulation would be some of the absolute contraindications to ECMO therapy in COVID-19 patients. 7,11 To ensure the ethical distribution of resources, the relative and absolute contraindications may vary with time as the health care resources get overburdened due to the progressing COVID-19 pandemic. Although not prospectively validated in COVID-19 patients, the pulmonary and extrapulmonary predictive survival models such as RESP and PRESET might serve as decision support in COVID-19 patients with ARDS to be placed on ECMO therapy.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Dual-site cannulation is preferred for COVID-19 patients for pulmonary support, as it can be performed safely at the bedside without the need for fluoroscopy or transesophageal echocardiography, so that fewer personnel need to come into the room. V-A-ECMO provides cardiac and circulatory support in addition to oxygenation 60 . Nonrandomized studies, case series, and reports of using ECMO as a bridge to recovery in ARDS during the 2009 influenza A (H1N1) epidemic suggest that the mortality rate is lower with ECMO 61 .…”
Section: Mechanical Assist Devices and Extracorporeal Devices In Multmentioning
confidence: 99%